Industrial Session on
“ Biotech and Biosimilar Products”
September 8, 2008
Kervansaray Hotel Lara, Antalya
Chaired by: Dr. Mahmut Tokaç (General Director of Pharmaceuticals and Pharmacy, Turkish Ministry of Healh)
Prof. Gary Walsh (University of Limerick, Ireland)
Dr. Mahmut Tokaç was born in Ünye in 1963. He graduated from Cerrahpaşa Faculty of Medicine in 1985 and freceived his Ph.D. on Deontology and Medical History in 2000 from İstanbul University Health Sciences Institute. Dr. Tokaç has worked as practitioner medicine in several medical institutions in different cities of Turkey. Between 1997 and 2003, he has worked as coordinator of ER call center and anbulance services for the city of İstanbul. Dr. Mahmut Tokaç was appointed as Vice Director of GDDP (General Directorate of Pharmaceuticals and Pharmacy) at the Turkish Ministry of Health and he has been serving as the Director of GDDP since 2005. Dr. Tokaç is married.
Dr. Gary Walsh was awarded his Ph.D. degree from the National University of Ireland at Galway in 1989. He is currently Associate Professor of Biotechnology at the University of Limerick, Ireland. Prior to joining the University of Limerick he worked within industry for several years and was a visiting Fulbright professor at the University of Georgia, in the United States. His research interests span various aspects of pharmaceutical and enzyme biotechnology, and he has or continues to supervise 20 post graduate and post doctoral students. His 191 publications include 7 authored books, 2 edited books, 11 book chapters and 55 journal articles. Three of his books are international students textbooks in the area of pharmaceutical biotechnology (Pharmaceutical Biotechnology, concepts and applications; Biopharmaceuticals: biochemistry and biotechnology and Proteins, biochemistry and biotechnology, all published by John Wiley & Sons, UK). He has presented guest/keynote papers at 22 international conferences. He has also served as editor, biotechnology section, of the European Journal of Pharmaceutics and Biopharmaceutics and as a member of the editorial boards of Biopharm. International, New Drugs and the Encyclopaedia of Industrial Biotechnology. He has also acted as scientific secretary and as a member of the board of governors of the European Association of Pharmaceutical Biotechnology. Gary Walsh teaches various aspects of pharmaceutical biotechnology at both undergraduate and taught post graduate level and served as acting Dean, Teaching & Learning, at the university of Limerick in 2004. He is also a former recipient of both his University’s excellence in teaching award and special achievement in research award.
SEPTEMBER 8, 2008
MONDAY - HALL B
Industrial Session on Biotech and Biosimilar Products
Chaired by:
Dr. Mahmut Tokaç General Director of Pharmaceuticals and Pharmacy, Turkish Ministry of Health, Turkey Prof. Gary Walsh University of Limerick, Ireland
10:20-10:40
Opening ceremony Dr. Mahmut Tokaç GDPP, Turkey Prof. Gary Walsh University of Limerick, IE
10:40-11:20
Prof. Gary Walsh University of Limerick, IE
Biosimilars, background and introduction
11:20-11:50
Dr. Jean-Louis Prugnaud (FR) L’Hopital Saint Antoine, FR
“European regulations in the context of biosimilars'
11:50-12:00
Group Photo
12:00-13:30
Lunch
13:30-14:00
Prof. Salomon Stavchansky University of Texas,USA
Lecture title to be announced
14:00-14:30
Dr. Connor O’Dea General Manager, Genemedix
Process Development and Manufacture of a Biosimilar Product
14:30-15:00
Dr. Andreas Premstaller Sandoz Biopharmaceuticals
Development of a biosimilar human product: Omnitrope
15:00-15:30
Coffee break
15:30-16:00
Dr. Carsten Brockmeyer Sandoz Biopharmaceuticals, D
Biosimilars, a case study: 'Erythropoietin'.
16:30-17:00
Dr. Alaine Cuiné BD Medical & Pharmaceutical Systems, FR
Which injectable formulations for tomorrow’s biotechnologies?
17:00-17:30
Dr. Thomas Bols Director Government Affairs, Europe
Amgen, BE
“Biosimilars: issues to be addressed for proper entry into clinical practice”
Dr. Gary Walsh was awarded his Ph.D. degree from the National University of Ireland at Galway in 1989. He is currently Associate Professor of Biotechnology at the University of Limerick, Ireland. Prior to joining the University of Limerick he worked within industry for several years and was a visiting Fulbright professor at the University of Georgia, in the United States. His research interests span various aspects of pharmaceutical and enzyme biotechnology, and he has or continues to supervise 20 post graduate and post doctoral students. His 191 publications include 7 authored books, 2 edited books, 11 book chapters and 55 journal articles. Three of his books are international students textbooks in the area of pharmaceutical biotechnology (Pharmaceutical Biotechnology, concepts and applications; Biopharmaceuticals: biochemistry and biotechnology and Proteins, biochemistry and biotechnology, all published by John Wiley & Sons, UK). He has presented guest/keynote papers at 22 international conferences. He has also served as editor, biotechnology section, of the European Journal of Pharmaceutics and Biopharmaceutics and as a member of the editorial boards of Biopharm. International, New Drugs and the Encyclopaedia of Industrial Biotechnology. He has also acted as scientific secretary and as a member of the board of governors of the European Association of Pharmaceutical Biotechnology. Gary Walsh teaches various aspects of pharmaceutical biotechnology at both undergraduate and taught post graduate level and served as acting Dean, Teaching & Learning, at the university of Limerick in 2004. He is also a former recipient of both his University’s excellence in teaching award and special achievement in research award.
